Pharmaceutical firm Pyridam Farma (PYFA) plans to launch the rights issue, offering 10.7 billion new shares, representing 95.24% of its enlarged capital, priced at Rp100 per share, to raise total proceeds of Rp1.07 trillion. To subscribe please click here
